Citation Impact
Citing Papers
Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
2010
Dual-color superresolution imaging of genetically expressed probes within individual adhesion complexes
2007 StandoutNobel
Cancer Incidence Among Canadian Kidney Transplant Recipients
2007
Potentiation of Cocaine‐Mediated Hepatotoxicity by Acute and Chronic Ethanol
1990
Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial
2004
The effect of anemia treatment on selected health-related quality-of-life domains: A systematic review
2003
Cadaver Donor Screening for Infectious Agents in Solid Organ Transplantation
2000
Chimerism of the Transplanted Heart
2002 Standout
SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12
2000
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
RENAL DISEASE ASSOCIATED WITH HEPATITIS C INFECTION AFTER KIDNEY AND LIVER TRANSPLANTATION1
2000
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
2005
Long-Term Impact of Hepatitis B, C Virus Infection on Renal Transplantation
2001
The Immune Reactivity Role of HCV-Induced Liver Infiltrating Lymphocytes in Hepatocellular Damage
1997
Hepatitis C infection and the patient with end-stage renal disease
2002
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
Microchimerism, GVHD, and tolerance in solid organ transplantation
2001
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
Improving de novo protein binder design with deep learning
2023 StandoutNobel
HEPATITIS C VIRUS AND ORGAN TRANSPLANTATION
1996
Drug-Induced Hepatotoxicity
2003 Standout
SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
1999 Standout
Prevalence and Management of Anemia in Renal Transplant Recipients: A European Survey
2003
Triggered release of therapeutic antibodies from nanodiamond complexes
2011
Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients
2005
Uric Acid and Cardiovascular Risk
2008 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Hepatotoxicity Associated with Cocaine Abuse
1992
Structural basis of immunosuppression by the therapeutic antibody daclizumab
2010
Machine Perfusion Preservation Improves Renal Allograft Survival
2007
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort1
2003
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Malignancy in Renal Transplantation
2004
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Chronic kidney disease
2011 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
MDRD Equations for Estimation of GFR in Renal Transplant Recipients
2005
Hemoglobin Targets for the Anemia of Chronic Kidney Disease
2004
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Association of Hepatitis C with Posttransplant Diabetes in Renal Transplant Patients on Tacrolimus
2002
Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease
1998
Routine renin-angiotensin system blockade in renal transplantation?
2002
Effects of Early and Late Intervention with Epoetin α on Left Ventricular Mass among Patients with Chronic Kidney Disease (Stage 3 or 4)
2004
Efficacy and tolerance of interferon-α2b in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment
1999
Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy
2004
Rhabdomyolysis
2007
Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the Centers for Disease Control and Prevention
2009
Chronic kidney disease: global dimension and perspectives
2013 Standout
Sex, haemoglobin and kidney disease: new perspectives
2005
Epidemiology of Anemia Associated with Chronic Renal Insufficiency among Adults in the United States
2002
Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients1
2002
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Hepatitis C and renal disease: an update
2003
Factors affecting the patency of arteriovenous fistulas for dialysis access
2011 StandoutNobel
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
COMBINED HISTOCOMPATIBILITY LEUKOCYTE ANTIGENMATCHED DONOR BONE MARROW AND RENAL TRANSPLANTATION FOR MULTIPLE MYELOMA WITH END STAGE RENAL DISEASE: THE INDUCTION OF ALLOGRAFT TOLERANCE THROUGH MIXED LYMPHOHEMATOPOIETIC CHIMERISM
1999
Anemia treatment in the pre-ESRD period and associated mortality in elderly patients
2002
HYPERLIPIDEMIA IN SOLID ORGAN TRANSPLANTATION
1997
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Uncomplicated Urinary Tract Infection
2012 Standout
Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
2012
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000 Standout
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Autosomal dominant polycystic kidney disease
2007
SAFETY AND EFFICACY OF TACROLIMUS IN COMBINATION WITH MYCOPHENOLATE MOFETIL (MMF) IN CADAVERIC RENAL TRANSPLANT RECIPIENTS1
2000
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Effect of Early Correction of Anemia on the Progression of CKD
2006
Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
1997
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Assessment of Racial Disparities in Chronic Kidney Disease Stage 3 and 4 Care in the Department of Defense Health System
2008
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
2011
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
Mixed chimerism and immunosuppressive drug withdrawal after hla-mismatched kidney and hematopoietic progenitor transplantation1
2002
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Chronic Kidney Disease
2016 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine1
2002
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease
2005
Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994).
2002
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Posttransplantation Diabetes
2002
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Hepatitis C infection in the transplant recipient.
1995
Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients
1995
Treatment of Dialysis Patients with Chronic Hepatitis C Using Pegylated Interferon and Low-Dose Ribavirin
2008
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
2006
Referral pattern of patients with end-stage renal disease at a public sector hospital and its impact on outcome.
2012
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Rituximab Therapy for De Novo Mixed Cryoglobulinemia in Renal Transplant Patients
2005
Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
2005
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Drug-induced liver disease
2000
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation
2013
HEPATITIS C INFECTION IN THE TRANSPLANT RECIPIENT
1995
Structural basis for reversible photoswitching in Dronpa
2007 StandoutNobel
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Works of David Roth being referenced
DETECTION OF ANTIBODY TO HEPATITIS C VIRUS IN RENAL TRANSPLANT RECIPIENTS
1991
Effects of Recombinant Human Erythropoietin on Renal Function in Chronic Renal Failure Predialysis Patients
1994
Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection
2002
Acute Rhabdomyolysis Associated with Cocaine Intoxication
1988
Barriers to successful care for chronic kidney disease
2005
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
2015
DESTRUCTIVE ALLOGRAFT FUNGAL ARTERITIS FOLLOWING SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION
1996
A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1
2005
Transmission of hepatitis C virus by kidney transplantation: impact of perfusion techniques and course of viremia post transplant
1995
Detection of Hepatitis C Virus Infection among Cadaver Organ Donors: Evidence for Low Transmission of Disease
1992
Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving prograf and cellcept in combination therapy
1997
SIX-YEAR CLINICAL EFFECT OF DONOR BONE MARROW INFUSIONS IN RENAL TRANSPLANT PATIENTS1
2001
A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine
1995
THE EFFECTS OF TISSUE-ASSOCIATED AND MHC CLASS II ANTIGEN PRESENTATION ON IN VITRO LYMPHOPROLIFERATIVE RESPONSES AGAINST CANINE LIVER AND KIDNEY CELL SUBPOPULATIONS
1991
The impact of hepatitis C virus infection on renal allograft recipients
1994
DE NOVO MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS IN HEPATITIS C VIRUS–INFECTED RENAL ALLOGRAFT RECIPIENTS
1995
PRIMARY IMMUNOSUPPRESSION WITH TACROLIMUS AND MYCOPHENOLATE MOFETIL FOR RENAL ALLOGRAFT RECIPIENTS1
1998
Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression
2001
The use of daclizumab as induction therapy in combination with tacrolimus and mycophenolate mofetil in recipients with previous transplants
2003
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4–5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial
2017
Hepatic dysfunction accompanying acute cocaine intoxication
1991
Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings
1997
Transplant-associated autoimmune mechanisms in human hepatitis C virus infection
1996
THE HUMAN BONE MARROW AS AN IMMUNOREGULATORY ORGAN1
1999
CONTINUING OBSERVATIONS ON THE REGULATORY EFFECTS OF DONOR-SPECIFIC BONE MARROW CELL INFUSIONS AND CHIMERISM IN KIDNEY TRANSPLANT RECIPIENTS1
1998
Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study
2005
DEPLETION OF HEPATITIS C VIRUS FROM PROCURED KIDNEYS USING PULSATILE PERFUSION PRESERVATION1,2
1994
Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.
1995
EVALUATION OF FLUVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA IN RENAL TRANSPLANT RECIPIENTS TAKING CYCLOSPORINE1
1996
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000